Reports suggest that the loss of heterozygosity (LOH) in the BRCA1 gene and DNA damage response (DDR) deficiency are strongly linked to the development of ovarian cancer (Bouwman et al., 2010; Gee et al., 2018; Weber and Ryan, 2015). This evidence concerns the gene BRCA1 and ovarian carcinoma.